Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.22 USD | +4.15% | -8.59% | +163.30% |
May. 09 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
Apr. 29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.30% | 1.13B | |
+30.30% | 48.16B | |
-0.05% | 41.73B | |
+43.17% | 41.03B | |
-5.31% | 28.77B | |
+10.87% | 25.59B | |
-22.02% | 18.96B | |
+9.26% | 12.92B | |
+28.58% | 12.03B | |
-2.64% | 11.77B |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology : SVB Leerink Adjusts Price Target on Cullinan Management to $54 From $48, Maintains Outperform Rating